Departmental Notices




466 NEW ZEALAND GAZETTE, No. 20 19 FEBRUARY 2009

Any person wanting to discuss this notice should contact Glaister Ennor Solicitors Nominee Company Limited,
c/o Glaister Ennor, Solicitors, 18 High Street, Auckland, or telephone (09) 356 8233.

Dated at Auckland this 5th day of February 2009.

Signed on behalf of the mortgagee, Glaister Ennor Solicitors Nominee Company Limited, by its solicitor and duly authorised agent:

GLAISTER ENNOR.

gn1309


Departmental Notices

Economic Development

Crown Entities Act 2004

Reappointment/appointment to the Accounting Standards Review Board

His Excellency the Governor-General of New Zealand has reappointed as a member, pursuant to section 28(1)(b) of the Crown Entities Act 2004; and appointed as chairperson,
pursuant to clause 1(2) of Schedule 5 of the Crown Entities Act 2004

Kevin John Simpkins, of Wellington

to the Accounting Standards Review Board, as established under the Financial Reporting Act 1993, for a term of five years commencing on 1 March 2009 and expiring on 28 February 2014.

Dated at Wellington this 12th day of February 2009.

HON SIMON POWER, Minister of Commerce.

go1387


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Arabloc
Active Ingredient: Leflunomide 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arabloc
Active Ingredient: Leflunomide 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arabloc
Active Ingredient: Leflunomide 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arava
Active Ingredient: Leflunomide 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arava
Active Ingredient: Leflunomide 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 20





✨ LLM interpretation of page content

⚖️ Notice of Entry into Possession of Mortgaged Land (continued from previous page)

⚖️ Justice & Law Enforcement
5 February 2009
Property Law Act 2007, Mortgagee, Possession, Glaister Ennor Solicitors Nominee Company Limited, Bay Street, Petone
  • Glaister Ennor, Solicitor

💰 Reappointment and Appointment to the Accounting Standards Review Board

💰 Finance & Revenue
12 February 2009
Crown Entities Act 2004, Accounting Standards Review Board, Appointment, Chairperson
  • Kevin John Simpkins, Reappointed and appointed as chairperson

  • HON SIMON POWER, Minister of Commerce

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act 1981, New Medicines, Distribution Consent, Arabloc, Arava, Leflunomide
  • Minister of Health